These findings suggested a new regulatory tool for counteracting AngII‐induced VSMCs proliferation, migration and phenotypic transformation as well as hypertensive angiopathy, providing novel insights into the treatment of hypertensive vascular diseases such as stroke, and heart and kidney failure. This evidence concerns the gene AGT and stroke disorder.